Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 5263-5270
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5263
Figure 3
Figure 3 Immunophenotypes of two patients. A: Case 1 tumor cells are diffuse CD4 positive (IHC, 200 ×), EnVision two-step method; B: Case 1 tumor cells are diffusively CD56 positive (IHC, 200 ×), EnVision two-step method; C: Case 1 tumor cells are diffusively CD43 positive (IHC, 200 ×), EnVision two-step method; D: Case 1 tumor cells are diffusively CD123 positive (IHC, 200 ×), EnVision two-step method; E: Case 2 tumor cells are diffuse CD4 positive (IHC, 200 ×), EnVision two-step method; F: Case 2 tumor cells are diffusively CD56 positive (IHC, 200 ×), EnVision two-step method; G: Case 2 tumor cells are diffusively CD43 positive (IHC, 200 ×), EnVision two-step method; H: Case 2 tumor cells are diffusively CD123 positive (IHC, 200 ×), EnVision two-step method. All bars are 50 μm.